Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...